Expression and reconstitution of NF-kappaB from insect cells using a baculovirus vector. 1997

T A Coleman, and K A Huddleston, and S M Ruben, and C A Rosen, and R Gentz
Human Genome Sciences, Inc., Rockville, Maryland 20850, USA. Tim_Coleman@hgsi.com

NF-kappaB is a pleiotropic transcriptional activator originally identified by its ability to regulate immunoglogulin kappa light chain expression. Purification of this DNA-binding complex demonstrated that NF-kappaB is a heterodimer composed of two subunits, NFKB1 and RelA. Previous studies have shown that truncated versions of these proteins could be expressed and purified from bacterial cells. In the present study, we utilize a baculovirus expression vector system (BEVS) to overexpress each subunit independently to produce homodimers or together to reconstitute functional NF-kappaB. These proteins can be enriched to >70% homogeneity on a kappaB-agarose DNA- affinity column. The purified proteins are active in DNA binding as measured by electrophoretic mobility shift assays. Finally, transcriptional activation of these recombinant proteins can be measured by their ability to activate a kappaB-CAT reporter plasmid in transiently transfected/infected SF-9 cells. Thus, BEVS provides a method for production of full-length, transcriptionally active NF-kappaB proteins.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D015533 Transcriptional Activation Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes. Gene Activation,Genetic Induction,Transactivation,Induction, Genetic,Trans-Activation, Genetic,Transcription Activation,Activation, Gene,Activation, Transcription,Activation, Transcriptional,Genetic Trans-Activation,Trans Activation, Genetic
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D016367 Baculoviridae Family of INSECT VIRUSES which contain polyhedron-shaped or ovocylindrical occlusion bodies. The genera include ALPHABACULOVIRUS; GAMMABACULOVIRUS; and DELTABACULOVIRUS (commonly known as NUCLEOPOLYHEDROVIRUSES) and BETABACULOVIRUS (commonly known as GRANULOVIRUSES). Baculovirus vectors are used for expression of foreign genes in insects and as BIOPESTICIDES for controlling insect populations. Baculovirus,Baculoviruses
D051996 Transcription Factor RelA A subunit of NF-kappa B that is primarily responsible for its transactivation function. It contains a C-terminal transactivation domain and an N-terminal domain with homology to PROTO-ONCOGENE PROTEINS C-REL. NF-kappa B p65 Subunit,NF-kappa B p65,NF-kappaB 65-kDa,Transcription Factor p65,p65 Transcription Factor,v-Rel Reticuloendotheliosis Viral Oncogene Homolog A,NF kappa B p65,NF kappa B p65 Subunit,NF kappaB 65 kDa,RelA, Transcription Factor,Transcription Factor, p65,p65, NF-kappa B,p65, Transcription Factor,v Rel Reticuloendotheliosis Viral Oncogene Homolog A

Related Publications

T A Coleman, and K A Huddleston, and S M Ruben, and C A Rosen, and R Gentz
February 1993, Archives of biochemistry and biophysics,
T A Coleman, and K A Huddleston, and S M Ruben, and C A Rosen, and R Gentz
January 2020, Methods in molecular biology (Clifton, N.J.),
T A Coleman, and K A Huddleston, and S M Ruben, and C A Rosen, and R Gentz
January 1992, European journal of biochemistry,
T A Coleman, and K A Huddleston, and S M Ruben, and C A Rosen, and R Gentz
January 1990, Methods in molecular biology (Clifton, N.J.),
T A Coleman, and K A Huddleston, and S M Ruben, and C A Rosen, and R Gentz
November 1988, Virology,
T A Coleman, and K A Huddleston, and S M Ruben, and C A Rosen, and R Gentz
July 1990, Gene,
T A Coleman, and K A Huddleston, and S M Ruben, and C A Rosen, and R Gentz
April 1992, The Journal of biological chemistry,
T A Coleman, and K A Huddleston, and S M Ruben, and C A Rosen, and R Gentz
February 1995, Molecular and cellular biochemistry,
T A Coleman, and K A Huddleston, and S M Ruben, and C A Rosen, and R Gentz
July 1986, Virus research,
T A Coleman, and K A Huddleston, and S M Ruben, and C A Rosen, and R Gentz
October 1988, Biotechnology and applied biochemistry,
Copied contents to your clipboard!